Pfizer Estimates $15 Billion In 2021 Sales For COVID-19 Vaccine

Sales of the Covid-19 vaccine developed by Pfizer and BioNTech could reach up to $15 billion in 2021 and go higher if Pfizer signs additional supply contracts, Pfizer said Tuesday.